Notice ID: 7d8e310f02c645e1b381f4b77ff349d3Combined Synopsis/Solicitation
Microbiology of FDA Regulated Foods, Agricultural Water, and Cosmetics
Archived on March 22, 2022. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM UTC−05:00
- Posted
- February 18, 2022
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 541380: Testing Laboratories and Services
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FOOD AND DRUG ADMINISTRATION
- Place of performance
- Silver Spring, MD, 20993
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- FDA-22-SOL-1240447
- Notice ID
- 7d8e310f02c645e1b381f4b77ff349d3
Description
The purpose of this Amendment No: 2 to provide respond to questions we have received as Attachment No: 6 and extend the closing date to March 7, 2022. End of Amendment No: 2 ************************************************************************************* The purpose of this Amendment No: 1 to replace Attahcment No: 1 RFP Questions Template with revised version which attached as Attachment No: 1 RFP Questions Template (Revised). End of Amendment No 1 ************************************************************************************* The objective of this IDIQ is to obtain baseline survey data on FDA-regulated food, agricultural water, cosmetics products, and environmental samples. These products shall be analyzed for the presence of and, in some cases, levels of one or several pathogens, including, but not limited to, Salmonella, Listeria monocytogenes, E. coli O157:H7, non-O157:H7 STECs, Shigella spp., Campylobacter spp., Vibrio spp., Staphylococcus aureus, Bacillus cereus, Cronobacter spp., COVID-19, Norovirus, hepatitis A, Cyclospora, and Cryptosporidium. The contractor shall conduct whole genome sequencing (WGS) of collections of food and environmental isolates, or other microorganisms of interest to FDA, have the capacity to submit the WGS data to NCBI database.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
FDA-22-SOL-1240447- Combined Synopsis
- 3×Combined SynopsisCurrentJan 31, 2022
Microbiology of FDA Regulated Foods, Agricultural Water, and Cosmetics
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
General Information Document Type: Presolicitation Synopsis Number: 75N98027Q00086 Posted Date: November 16, 2026 Original Response Date: November 26, 2026 Current Response Date: November 26, 2026 Set Aside: N/A NAICS Code: 541380 Contracting Office Address National Institutes of Health (NIH), Office of the Director (OD) Office of Logistics and Operations (OLAO) Office of Acquisition and Logistics Management (OALM) Hospital and Laboratory Support Division 6701 Rockledge Drive Bethesda, MD 20817 Description INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to: Eminent Services Corp 7495 New Technology WAY Frederick, Maryland 21703 NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 541380 with a Size Standard $19,000,000. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION Title: Storage and monitoring of ManNac for FDA regulations Background Information: Under this task order, the contractor will independently provide support services to satisfy the overall operational objectives of the National Human Genome Research Institute (NHGRI). The refrigerated storage of the clinical grade drug-in-sachet needs to be conducted under strict temperature control and FDA-regulatory requirements. NHGRI wants to contract a company for long-term refrigerated storage of a large batch of our unlabeled investigational drug N-acetylmannosamine (ManNAc), the drug is packaged as powder-in-sachets and stored in 16 boxes (8x12x14’’box dimensions) and contain 600 sachets/box. NHGRI plans to use this drug in future clinical trials of ManNAc for other indications, such as GNE-related thrombocytopenia or nephrotic disease. NHGRI anticipates storing this batch of unlabeled drug at a company for a period of up to 2 years. The refrigerated storage of the clinical grade drug-in-sachet needs to be conducted under strict temperature control and FDA-regulatory requirements. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by November 26, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98027Q00086. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted. "All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.” | 51% | Pre-Solicitation | 11/26/2026 |
1. PURPOSE The Department of Veterans Affairs (VA) is conducting market research to identify qualified and interested firms capable of providing routine and surge Heterotrophic Plate Count (HPC) testing of potable waterlines at VA facilities along the Gulf Coast. The Government seeks capability statements from Small Businesses (including SDVOSB/VOSB) and other than small businesses, and from GSA Multiple Award Schedule (MAS) holders under SIN 541380 (Testing Laboratory Services). This RFI/Sources Sought Notice (SSN) is issued solely for information and planning purposes and does not obligate the Government to award a contract. 2. BACKGROUND & REGULATORY CONTEXT HPC (Standard Methods 9215) estimates live culturable heterotrophic microorganisms in water and is used to monitor premise plumbing microbiological condition; consistent method/media selection is essential to preserve trend comparability. Short, strict hold times for HPC samples require reliable local logistics (cooling/transport and initiation of analysis within program limits—commonly ≤24 hours, and in some jurisdictions ≤8 hours for compliance). In healthcare settings, CDC expects facilities to operate comprehensive water management programs; EPA notes HPC can indicate general distribution-system water quality status, and ≤500 CFU/mL is used for disinfectant-residual equivalency under SWTR. 3. DRAFT SCOPE OF WORK (SUMMARY) 3.1 Methods Contractor shall perform HPC under Standard Methods (SM) 9215 using acceptable variants (e.g., 9215B, 9215D/R2A, 9215E). Contractor shall document media, incubation temperature, and duration for each sample; the selected method/media shall remain consistent throughout the period of performance for comparability of trends. 3.2 Certifications & Accreditation Contractor shall hold current state certification/accreditation explicitly listing HPC under SM 9215 for the place(s) of performance (e.g., MSDH Drinking Water Laboratory Certification in Mississippi; Florida DOH/NELAP in Florida); ISO/IEC 17025 accreditation covering HPC is preferred. Copies of certificates and scopes must be provided. 3.3 Sample Handling & Logistics Contractor shall provide sampling containers, labels, chain‑of‑custody (COC) forms, coolers, and transport ice/ice packs; maintain 0–10 °C during transport; prevent freezing. Contractor shall initiate HPC analysis within applicable program hold times and in no case exceed 24 hours from collection unless stricter state limits are applicable. 3.4 Turnaround & Reporting Standard reporting shall be provided within 48 hours of laboratory receipt. Per‑sample reports must include sample ID/location, collection and receipt timestamps, method/media/incubation conditions, HPC result in CFU/mL, and QC/batch identifiers. Contractor shall flag and notify the COR for any sample exceeding 500 CFU/mL and provide interpretive notes consistent with EPA guidance. 3.5 Emergency/Surge Capability Contractor shall provide rapid response capability for urgent events (e.g., main breaks, disinfection upsets) and identify surge capacity (peak samples/day) to meet VA needs. 4. ACQUISITION PATHWAYS & MANDATORY SOURCES The Government anticipates competing this requirement via Open Market or GSA MAS SIN 541380 if available. Nothing in this RFI commits the Government to a particular path. 5. SMALL BUSINESS & VETERANS FIRST VA will consider the results of this market research to determine small business set‑asides and/or the use of Veterans First authorities. SDVOSB/VOSB respondents should indicate VetCert verification status. Any decision to set aside or use VAAR Subpart 819.70 sole‑source authorities (≤$5M) will be made at the Government’s discretion and in the best interest of the Government based on market research outcomes. 6. WHAT TO SUBMIT (Capability Statement – 10 pages max) A. Firm Information: Legal name, UEI, CAGE, business size/status (SB, SDVOSB, VOSB, HUBZone, WOSB), primary NAICS (541380) and any relevant NAICS. B. MAS Information (if applicable): GSA MAS contract number; confirmation of SIN 541380 listing; link to eLibrary T&Cs/price list. C. Certifications: Current state certification/accreditation scopes explicitly listing SM 9215 HPC (e.g., MSDH, FL DOH/NELAP) and ISO/IEC 17025 scope (if held). Attach certificates/scopes. D. Methods: Identify SM 9215 variant(s) used (B/D/R2A/E) and your approach to method/media consistency for trend comparability. E. Logistics & TAT: Confirm ability to meet hold‑time limits (≤24 h minimum; stricter limits prevail) and report within ≤48 h; describe courier coverage, latest daily lab receipt times, and COC controls. F. QA/QC: Proficiency testing participation, batch QC practices, and LIMS/portal capabilities for electronic reporting. G. Past Performance: Healthcare water microbiology clients (VA/DoD/hospitals). Provide references (optional). H. Pricing (Non‑binding for planning): Rough order‑of‑magnitude per‑sample pricing; field collection fees; surge/expedite rates. 7. GOVERNMENT FURNISHED INFORMATION With any future solicitation, the Government may furnish sampling maps, historical HPC data for trend continuity, and site points of contact. (Not provided at the RFI stage.) 8. Instructions and Response Guidelines: Sources Sought responses are due by September 23, 2026 at 10:00 am (CST) via email to anthony.marion2.gov. All Questions shall be submitted by September 17, 2026 at 10:00 pm (CST) via email to anthony.marion2.gov. Telephone requests or inquires will not be accepted. Public Information will not be provided and shall be utilized to the full extent possible. This a New Requirement. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. If a solicitation is released, it will be synopsized on Contracting Opportunities (https://beta.sam.gov/) website or GSA. It is the responsibility of the interested parties to monitor these sites for additional information pertaining to this Sources Sought, or future RFP/RFQ. 9. DISCLAIMER This RFI is not a request for proposals or quotations. The Government will not reimburse costs incurred for responding. The Government reserves the right to use information provided to inform the acquisition strategy. If a solicitation is issued, it will be posted separately on SAM.gov. | 44% | Market Research | 09/25/2026 |
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. This procurement is for ACL TOP 750 Analyzers kits and reagents used in patient care testing. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.500 This subpart authorizes the use of simplified procedures for the acquisition of supplies and services in amounts greater than the simplified acquisition threshold but not exceeding $9 million ($15 million for acquisitions as described in 13.500(c)), including options, if the contracting officer reasonably expects, based on the nature of the supplies or services sought, and on market research, that offers will include only commercial products or commercial services. Contracting officers may use any simplified acquisition procedure in this part, subject to any specific dollar limitation applicable to the particular procedure. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to Ryssa.nix@nih.gov by close date. Notice Type: Notice of Intent NAICS Code: 541380 PSC Code: J066 Posted Date: 11/16/2026 Close Date: 11/27/2026 12pm EST End User IC: Clinical Center POC Name: Ryssa Nix Email Address: Ryssa.nix@nih.gov | 42% | Pre-Solicitation | 11/27/2026 |
THIS IS A SOURCES SOUGHT ANNOUNCEMENT ONLY. It is neither a solicitation announcement nor a request for proposals or quotes and does not obligate the Government to award a contract. Requests for a solicitation will not receive a response. Responses to this sources sought must be in writing. The purpose of this sources sought announcement is for market research to make appropriate acquisition decisions and to gain knowledge of potential qualified Small Businesses interested and capable of providing the services described below. NIH-OD-SS-27-000058 The information gained from this market research will help the National Institutes (NIH) Clinical Center (CC) plan for its acquisition strategy. Potential Large and Small Businesses shall include business information outlined in the section below as a part of their response. Complete responses to this notice shall be in the following format: SAM UEI Number and CAGE code Company Name Company Address, City, State and Zip Code Company Point of Contact, Email Address and Telephone Number Current GSA Schedule appropriate to this Sources Sought of other FAR Part 8 considerations Socioeconomic Status: (i.e., HUBZone, 8a, Small Business, Women Owned Small Business, Veteran-Owned Small-Business, etc.) https://www.sam.gov. Provide a capability statement that addresses the organizations qualifications and ability to perform as a contractor for the work described in the Statement of Work. The NIH Clinical Center Office of Research Support and Compliance (ORSC) is seeking a qualified and experienced contractor to provide project management and coordination of routine and emergent qualification, calibration/PM and certification services, including repairs and replacements, for the departments/ICs located at the NIH’s Bethesda, MD campus. Please see attached SOW for more details. Contractors shall not reach out to the customer for any questions or clarifications. All communications must go through contracting. ****************************************************************************** Important information: The Government is not obligated to nor will it pay for or reimburse any costs associated with responding to this source sought synopsis request. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. No sub-contracting opportunity is anticipated. NAICS: The North American Classification System (NAICS) code for this acquisition is 541380. PSC: H966 Notice to potential offerors: All offerors who provide goods or services to the United States Federal Government must be registered and have an active registration in the System for Award Management (SAM) at www.sam.gov and complete Online Representations and Certifications Application (ORCA). All interested Offerors should submit information by e-mail to ryssa.nix@nih.gov. Please use subject line “Response to NIH-OD-SS-27-000058”. All information submissions shall be received no later than noon on November 15, 2026. | 42% | Pre-Solicitation | 11/15/2026 |
INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to: Alcami Corporation 2320 Scientific Park DR Wilmington, North Carolina 28405-1800 NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 541380 with a Size Standard $16.6M. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION Title: Stability Testing for ManNAc Drug Product produced in Campaigns 5 and 6. Stability testing will occur under regulatory compliance Background Information: NHGRI was gifted 48kg of unlabeled drug ManNAc (powder-in-sachet) in September 2025, and agreed to take over the FDA-required, mandatory, stability testing program of this drug that has been ongoing at Alcami Corporation since June 2024. The gifted drug was produced in 2 campaigns, Campaign 5 (C5, June 2024) and Campaign 6 (C6, September 2024). NHGRI plans to use the donated clinical grade drug for upcoming clinical trials. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by November 9, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98027Q00040. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted. "All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.” | 42% | Pre-Solicitation | 11/09/2026 |
Additional Details
Solicitation Number
FDA-22-SOL-1240447
Archive Date
Mar 22, 2022
Office Address
ROCKVILLE, MD, 20857